Tedizolid for treatment of acute bacterial skin and skin structure infections.

about

Tedizolid for treatment of acute bacterial skin and skin structure infections.

Item

http://www.wikidata.org/entity/Q38554583

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tedizolid for treatment of acute bacterial skin and skin structure infections.

@en

type

Item

label

Tedizolid for treatment of acute bacterial skin and skin structure infections.

@en

prefLabel

Tedizolid for treatment of acute bacterial skin and skin structure infections.

@en

P1476

Tedizolid for treatment of acute bacterial skin and skin structure infections.

@en

P2093

Lü Xiaoju

http://www.w3.org/2001/XMLSchema#string

Ye Hui

http://www.w3.org/2001/XMLSchema#string

P2860

Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety summary

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

Tigecycline use in serious nosocomial infections: a drug use evaluation.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe

Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods.

Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ ST398.

A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.

Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.

Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug

P304

1051-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2015.1073107

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26211946

http://www.w3.org/2001/XMLSchema#string